Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up.
Guerin, Mathilde
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up. [electronic resource] - World journal of surgical oncology Sep 2013 - 243 p. digital
Publication Type: Case Reports; Journal Article
1477-7819
10.1186/1477-7819-11-243 doi
Adult
Brain Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Disease Progression
Female
Follow-Up Studies
Humans
Kidney Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Mediastinal Neoplasms--drug therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Protein Kinase Inhibitors--therapeutic use
Sorafenib
Treatment Outcome
Major response with sorafenib in advanced renal cell carcinoma after 14 years of follow-up. [electronic resource] - World journal of surgical oncology Sep 2013 - 243 p. digital
Publication Type: Case Reports; Journal Article
1477-7819
10.1186/1477-7819-11-243 doi
Adult
Brain Neoplasms--drug therapy
Carcinoma, Renal Cell--drug therapy
Disease Progression
Female
Follow-Up Studies
Humans
Kidney Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Mediastinal Neoplasms--drug therapy
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Protein Kinase Inhibitors--therapeutic use
Sorafenib
Treatment Outcome